Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

4
Tata Motors restarts talks to sell engineering unit stake

2018-07-20 livemint
Mumbai: Tata Motors Ltd., the owner of Jaguar Land Rover, has restarted talks on the sale of a stake in its engineering unit just months after a deal with Warburg Pincus was called off, people with knowledge of the matter said.
500470 TTST TATASTEEL TATLY TTQQY 500570 TATAMOTORS 500770 TTM TATACHEM

0
Tata Chemicals Limited - Updates

2018-07-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
TTQQY 500770 TATACHEM

4
Podcast | Pick of the day - NCLT okays Tatas#39; bye bye to Cyrus Mistry

2018-07-09 moneycontrol
It appears there is finally some resolution in the eighteen-month-long battle between the Tata Sons and Cyrus Mistry at the National Company Law Tribunal (NCLT). Today, the NCLT dismissed Cyrus Mistry’s plea for his alleged illegal removal from the post of Tata Sons’ Chairman. And that is our Pick of the Day.
500408 TTML TATACOFFEE 500800 BHUSANSTL TTAZF TTQQY BHRQY TATACOMM TTNQY TATACHEM TTAEY 532301 TGBL 500470 532540 TATAINVEST TATASPONGE 501301 500570 BHARTIARTL TATAMOTORS 500770 500055 513010 TGBA TATAMETALI TATAPOWER 513434 532454 TTST TATASTEEL TATLY 532371 TPCL TATAELXSI TCS 500400 500483 TATAGLOBAL TTM

4
NCLT ruling: Tata Motors, Tata Coffee jump 2%, TCS falls over 1%

2018-07-09 thehindubusinessline
Shares of various Tata group companies witnessed a mixed trend after the National Company Law Tribunal (NCLT) dismissed the pleas of Cyrus Mistry against Tata Sons for removing him as Chairman.
TATACOFFEE TATAPOWER TTQQY TTNQY TATACHEM 532301 500470 532540 TTST TATASTEEL TATLY TPCL 500400 TCS 500570 TATAMOTORS 500770 TTM

4
Tata Group stocks rally 1-5% after NCLT rules in Tata Sons#39; favour in Cyrus Mistry case

2018-07-09 moneycontrol
Tata Group stocks gained on Monday after the National Company Law Tribunal ruled in favour of Tata Sons against Cyrus Mistry's plea with regards to his removal as Tata Sons Chairman.
500408 TTML TTQQY TATACOMM TTNQY TATACHEM 500470 532540 TATAINVEST TATASPONGE 501301 500570 TATAMOTORS 500770 513010 TATAMETALI TATAPOWER 513434 TTST TATASTEEL TATLY 532371 TPCL TATAELXSI TCS 500400 500483 TTM

0
Tata Global Beverages board may weigh revamp plan: N. Chandrasekaran

2018-07-06 livemint
Kolkata: Tata group chairman N. Chandrasekaran on Thursday said the board of Tata Global Beverages Ltd (TGBL) may consider a restructuring proposal to bring together the group’s foods and beverages businesses. On Tuesday, Bloomberg had reported that Tata Chemicals Ltd’s salt and lentils businesses could be carved out and merged with TGBL. Chandrasekaran said there is “no concrete proposal” yet.
532301 TGBL 500800 TATACOFFEE TGBA TTAZF TTQQY TATAGLOBAL 500770 TTAEY TATACHEM

0
Tata considers consolidating food beverages business into a single company: Report

2018-07-04 moneycontrol
Tata Group may integrate its food and beverages businesses into a single company, said a Bloomberg report citing sources.
532301 TGBL 500800 TATACOFFEE TGBA TTAZF TTQQY TATAGLOBAL 500770 TTAEY TATACHEM

0
Tata plans to merge food and beverage businesses

2018-07-03 livemint
Mumbai: Tata Group, India’s biggest conglomerate, is evaluating a proposal to integrate its food and beverage businesses into a single company, people with knowledge of the matter said.
532301 TGBL 500800 TATACOFFEE TGBA TTAZF TTQQY TATAGLOBAL 500770 TTAEY TATACHEM

0
Tata Chemicals Limited - Updates

2018-07-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
TTQQY 500770 TATACHEM

0
Tata Chemicals Limited - Updates

2018-07-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
TTQQY 500770 TATACHEM

5
Closing Bell: Sensex rises 114 pts, Nifty ends tad below 10,700; pharma, auto, IT outshine

2018-07-03 moneycontrol
Global Update: Asian stocks closed mixed as investors remained cautious ahead of a July 6 deadline when the US is set to impose tariffs on $34 billion worth of goods from China. Beijing is then expected to respond with charges of its own on US goods, reports CNBC.
500325 UBL TTQQY 532478 TATACHEM CADILAHC 532321 BJJQY 500570 500770 RLNIY 513010 AXB MRZUY 532500 AXBA BAJAJFINSV BAJFINANCE 532670 TATASTEEL TATLY MARUTI 500180 KOTAKBANK 507458 523204 SSWL 513262 533271 RELIANCE IDBI 532737 ASHOKA 532978 RENUKA 532215 ABAN 500470 AXISBANK RIGD TATASPONGE HDFCBANK NIHARINF TATAMOTORS 500034 500116 KMBKY TATAMETALI IBN UBHOLDINGS 513434 532967 KIRIINDUS UNBWY CDLYY AXBKY ICICIBANK TTST EMKAY HDB 532174 531083 500247 TTM

14
Broker's Call: Tata Chem (Buy)

2018-07-02 thehindubusinessline
Recently, the stock price of Tata Chemicals corrected by about 12 per cent from 52-week high of ₹787 despite reporting good set of numbers in the recent quarters.
500470 500116 TTST TATASTEEL TATLY IDBI TTQQY 500770 TATACHEM

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...